Viewing Study NCT00720304


Ignite Creation Date: 2025-12-24 @ 9:17 PM
Ignite Modification Date: 2025-12-28 @ 7:14 PM
Study NCT ID: NCT00720304
Status: COMPLETED
Last Update Posted: 2024-08-22
First Post: 2008-07-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck
Sponsor: Case Comprehensive Cancer Center
Organization: